Literature DB >> 3038441

IL-2 receptor and HLA class II antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases.

E Tournier-Lasserve, O Lyoncaen, E Roullet, M A Bach.   

Abstract

The presence of IL-2 receptor and HLA class II antigens as detected by monoclonal antibodies on mononuclear cells from both cerebro-spinal fluid (CSF) and peripheral blood was examined by cytofluorographic analysis in patients with multiple sclerosis (MS) and other neurological diseases. CSF as compared to blood was enriched in cells expressing IL-2 receptor and HLA class II molecules both in MS patients and in other inflammatory diseases of the central nervous system suggesting that activated T-cells concentrate within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038441      PMCID: PMC1542620     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  CSF cells in multiple sclerosis: monoclonal antibody analysis and relationship to peripheral blood T-cell subsets.

Authors:  S L Hauser; E L Reinherz; C J Hoban; S F Schlossman; H L Weiner
Journal:  Neurology       Date:  1983-05       Impact factor: 9.910

2.  In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.

Authors:  D A Hafler; D A Fox; M E Manning; S F Schlossman; E L Reinherz; H L Weiner
Journal:  N Engl J Med       Date:  1985-05-30       Impact factor: 91.245

3.  Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid.

Authors:  N Cashman; C Martin; J F Eizenbaum; J D Degos; M A Bach
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

4.  Comparison of the response to phytohemagglutinin, of peripheral blood mononuclear cells and cerebrospinal fluid lymphocytes in multiple sclerosis and other neurological diseases. Determination of the frequency of the precursor cells by a limiting dilution analysis.

Authors:  E Tournier-Lasserve; E Roullet; O Lyoncaen; M A Bach
Journal:  Acta Neurol Scand       Date:  1986-07       Impact factor: 3.209

5.  Sequential expression of T cell activation (Tac) antigen and Ia determinants on circulating human T cells after immunization with tetanus toxoid.

Authors:  A Yachie; T Miyawaki; N Uwadana; S Ohzeki; N Taniguchi
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

6.  The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.

Authors:  A S Bellamy; V L Calder; M Feldmann; A N Davison
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

7.  Immune cell populations in cutaneous delayed-type hypersensitivity.

Authors:  J L Platt; B W Grant; A A Eddy; A F Michael
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

8.  Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization.

Authors:  D T Yu; R J Winchester; S M Fu; A Gibofsky; H S Ko; H G Kunkel
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

9.  Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content.

Authors:  T Cotner; J M Williams; L Christenson; H M Shapiro; T B Strom; J Strominger
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

10.  Detection and functional studies of p60-65 (Tac antigen) on activated human B cells.

Authors:  L K Jung; T Hara; S M Fu
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

  10 in total
  9 in total

Review 1.  T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  F T Rotteveel; C J Lucas
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  Dual labelling of circulating CD8 cells in patients with multiple sclerosis.

Authors:  P J Hughes; P F Kirk; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

3.  Determination of activated lymphocytes in peripheral blood of patients with multiple sclerosis.

Authors:  A D Crockard; T A McNeill; J McKirgan; S A Hawkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

4.  The need for a new strategy for the treatment of multiple sclerosis.

Authors:  A N Davison
Journal:  J Neurol       Date:  1988-07       Impact factor: 4.849

5.  Evidence for a missed signal to the CD8+ cells in CSF of multiple sclerosis patients.

Authors:  M Saresella; A Grope; L Speciale; R Mancuso; R De Benedictis; D Caputo; P Ferrante
Journal:  Ital J Neurol Sci       Date:  1995-10

6.  CSF T-cell subsets in multiple sclerosis: relationship to cerebrospinal fluid myelin basic protein and clinical activity.

Authors:  A Salmaggi; L LaMantia; C Milanese; G Bianchi; M Eoli; A Campi; A Nespolo
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

7.  Degradation of human myelin in vitro by leucocytes from patients with multiple sclerosis.

Authors:  S J Owen; C M Watson; A N Davison
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

8.  Lymphocyte activating factor activity in the serum and cerebrospinal fluid of patients with multiple sclerosis.

Authors:  D Donati; P Annunziata; G C Guazzi; D Boraschi; A Tagliabue
Journal:  Ital J Neurol Sci       Date:  1990-02

9.  Relative increase of inflammatory CD4+ T cells in the cerebrospinal fluid of multiple sclerosis patients and control individuals.

Authors:  F T Rotteveel; B Kuenen; I Kokkelink; A Meager; C J Lucas
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.